Ograniczanie wyników

Czasopisma help
Autorzy help
Lata help
Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 49

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 3 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych:  Streptococcus suis
help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 3 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
An increasing number of S. suis strains showing resistance to commonly used antibiotics have been identified over the last years. The aim of the study was to determine the antibiotic susceptibility of Polish field S. suis strains using the broth microdilution method. The following antibiotics were included in the test: penicillin, ampicillin, ceftiofur, gentamicin, neomycin, spectinomycin, erythromycin, tylosin, tiamulin, chlotretracycline, oxytetracycline, enrofloxacin, sulphadimetoxin, sulphachloropyridazine, sulphathiazole, sulphamethoxazole with trimethoprim and florphenicol. The S. suis strains tested were collected between 1996-2005 from pigs indicating nervous symptoms, respiratory tract disorders and/or arthritis. The necropsy hyperaemia of meninges revealed inflammation of lungs and joints and the presence of serofibrinous exudate on the pericardium. The results of the study demonstrate the high level of susceptibility of tested strains to b-lactams (about 100% of susceptible strains), florphenicol (98%), gentamycin and a combination of sulphamethoxazole and trimethoprim (95%), enrofloxacin and spectinomycin (90.37%). A large percentage of strains were resistant to chlortetracycline (49%), oxytetracycline (40%), erytromycin and tylosin (50%) and to sulphonamides (50.37%). Most strains were susceptible to the lowest concentrations of b-lactams and sulphametoxazole with trimethoprim. The greatest antimicrobial activity was obtained for florphenicol, enrofloxacin, spectinomycin and gentamicin when the highest concentration of antibiotics was used in the study. The presented study confirms the high susceptibility of Polish field S. suis strains to the antibiotics recommended for treating streptococci. Positive therapeutic effects should be expected after using b-lactams, florphenicol and sulphonamides with trimethoprim, gentamicin and fluoroquinolones.
The aim of the study was to evaluate biochemical features of 575 Polish isolates of S. suis from pigs with symptoms of streptococcosis and to improve methods of identification of the pathogen. The following tests were used to evaluate biochemical features of the strains: raffinose, inulin, mannitol, arginine and esculin fermentation, and production of acetoin, β-glucuronidase as well as amylase (on starch agar plates). Typical reactions were observed in 538 isolates (94%). The highest number of positive results was obtained in the β-glucuronidase production test in which 100% of the isolates demonstrate activity of mentioned enzyme. Since positive results were evidenced in 563 isolates (98%), raffinose fermentation was also a specific feature of the tested isolates. Less specific (93% of positive strains) results were proved for the following tests: acetoin and amylase production as well as inulin fermentation. Arginine dihydrolase activity was demonstrated in 523 tested isolates (91%) and 69% had the ability to hydrolyze esculin. The least specific result was obtained in the mannitol fermentation test: 33% of the typical reactions. 14 biochemical profiles were estimated among the analyzed isolates. 60% of the strains were classified in groups B and H. In group H only the strains with typical for S. suis pattern, reaching 22.3% of the tested isolates, were placed. This study confirmed S. suis to be highly heterogenous in biochemical profiles. In our opinion the evaluation of biochemical features is not a universal method and should not be considered as a basis for bacterial identification. This method can be used as an additional test for S. suis identification, supplemented by other, more reliable techniques.
The study evaluated the status of pigs immunological systems during streptococci and mixed infections of the respiratory tract caused by S. suis, Mhp and PPRSV. T lymphocytes, including the proportions of Th and Tc subpopulations, as well as B lymphocytes were examined. Additionally, CD2+ and CD8+ co-expression with the receptor for IL-2 (CD25) was analyzed. Immunodetection was performed using pairs of monoclonal antibodies against CD2 and CD21, CD4 and CD8 as well as CD5 and CD8, with isotype specific polyclonal antibodies conjugated to fluorochromes. Infections caused by S. suis as well as mixed infections of the respiratory tract resulted in an increase in the total blood leukocyte count, noted in the peak of the disease as well as 4 weeks later. However different mechanisms of specific cellular defense were apparent during streptococci and poliethiological respiratory infections in the pigs. An increase in the percentage of Tc lymphocytes and double positive CD4+CD8+ cells without a decrease in the number of B lymphocytes was noted in animals infected with S. suis. An increase in the number of Th and Tc double positive lymphocytes as well as NK cells was observed during infections caused by S. suis, Mhp and PRRSV. Additionally, a significant decrease of CD2+ and CD8+ activated T cells co-expressed with CD25 was observed in this group of animals accompanied by an increase in the population of the above cells without the expression of IL-2R receptor.
The aim of the study was to determine ceftiofur sensitivity of Streptococcus suis isolated from pathologically altered brains and joints of pigs with streptococci compared with the efficacy of treating two diverse forms of Streptococci infections in pigs (neurological and joint infections) with the same antibiotic depending on the severity of the clinical signs. The study was carried out on two farms - “P” and “W”. The results of the in vitro study demonstrated that 98.5% of the 67 Streptococcus suis isolates were sensitive to ceftiofur. Only one isolate from the joint was medium sensitive. The efficacy of the treatment (in vivo studies) in stage I of both the neurological form (apathy, auricular symptoms) and articular form (lameness, lack of evident swelling or mild swelling of one joint) of streptococcal disease proved to be significantly high on the farms (between 90.3-100%). The efficacy of treating more severe cases was lower and the course treatment was also longer. The proportion of recoveries in the neurological form (increase of body temperature above 41.0°C and in coordination) of streptococcal infections ranged from 66.7% on farm “W” to 72.8% on farm “P”. The results obtained in analogous groups of animals with moderately severe joint infections (lameness and evident swelling of one joint) ranged from 47.7% on farm “W” to 56.4% on farm “P”. The proportion of the recovered animals affected with neurological symptoms of stage III (lateral position, rowing movements) was 44.4% on “P” farm and merely 28.6% on farm “W”. A positive outcome of polyarthritis treatment during the three week observation period was noted in 10.7% of the cases on farm “P” and in only one weaner (4.5%) on farm “W”. Treatment failures of the articular form of streptococcal infections compared to the neurological form were not estimated in terms of losses but rather as chronic inflammations persisting beyond the observation period and requiring further therapeutic procedures or, more frequently, culling of the animals. It may be concluded that ceftiofur is characterized by its significant efficacy in treating clinical symptoms which have been diagnosed early and cured. The in vivo studies, where there was an intensification of the disease data, indicated the antibiotic’s efficacy and good penetration into joints and cerebrospinal fluid during inflammation. Speed in diagnosing and treating an ongoing S.suis infection plays a critical role in the efficacy of the therapy.
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 3 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.